• Ciprofloxacin in Research: Plasmid-Mediated Resistance Dynam

  2026-06-01

  Explore how Ciprofloxacin, a fluoroquinolone antibiotic, serves as a key tool for dissecting plasmid-mediated resistance transmission in multidrug-resistant bacteria. This article offers novel insights into molecular mechanisms and practical assay optimization, grounded in recent evidence.

• Caspase-8 Fluorometric Assay Kit: Precision Tools for Apopto

  2026-06-01

  Explore how the Caspase-8 Fluorometric Assay Kit advances apoptosis and pyroptosis research by enabling precise measurement of caspase-8 activity. This article delivers a unique, evidence-driven perspective on integrating mechanistic insights and protocol optimization for translational cell death studies.

• Immune-Modulatory Effects of Epigenetic Inhibitors in Melano

  2026-05-31

  Anichini et al. systematically mapped transcriptional and immune-related changes induced by distinct classes of epigenetic drugs in melanoma cell lines. Their findings reveal that DNMT inhibition, particularly with guadecitabine, most strongly upregulates immune signatures relevant for immunotherapy, providing a mechanistic rationale for combinatorial treatment strategies.

• Peroxidasin Drives Glycolytic Malignancy in Glioblastoma via

  2026-05-30

  This study identifies peroxidasin (PXDN) as a critical driver of glycolytic metabolism and malignant progression in glioblastoma, acting through regulation of lactate dehydrogenase A (LDHA). The findings highlight PXDN as a potential diagnostic marker and therapeutic target for GBM, with direct implications for metabolic cancer research.

• DMG-PEG2000-NH2: Protocol Enhancements for Liposomal Drug De

  2026-05-29

  DMG-PEG2000-NH2 empowers biomedical researchers to build robust, biocompatible lipid nanoparticles and liposomes for efficient therapeutic delivery. This guide demystifies experimental workflows, highlights troubleshooting strategies, and translates landmark antibiotic development insights into actionable protocol tips for NH2-PEG derivative use.

• IWR-1-endo: Wnt Signaling Inhibitor for High-Impact Research

  2026-05-29

  IWR-1-endo stands out as a nanomolar-potency Wnt signaling inhibitor, empowering researchers to dissect Wnt/β-catenin pathway dynamics in cancer and regenerative models. With robust protocol versatility and data-driven efficacy, this APExBIO reagent streamlines both routine and advanced workflows in colorectal cancer research and beyond.

• RCN2 Drives Metastasis and Drug Resistance in ESCC via PI3K-

  2026-05-28

  This study elucidates the mechanistic role of RCN2 in promoting metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) via UBR5-mediated degradation of PPP2CA, leading to activation of the PI3K-AKT signaling pathway. These findings reveal RCN2 as a potential therapeutic target and underscore the centrality of PI3K-AKT axis dysregulation in ESCC progression and treatment failure.

• Tetrahedral DNA Frameworks Enhance Enzymatic Oligonucleotide

  2026-05-28

  This study demonstrates how a highly ordered tetrahedral DNA nanostructure (TDN) interface improves enzymatic oligonucleotide synthesis (EOS) by optimizing primer orientation and enzyme accessibility. The approach yields more accurate and efficient DNA synthesis, with significant implications for DNA information storage and advanced nucleic acid probe development.

• Uremic Toxins and PEO Density: Impacts on Protein Adsorption

  2026-05-27

  This study systematically investigates how uremic toxins—including 4-ethylphenyl sulfate—alter plasma protein adsorption on methoxy-PEO surfaces. The findings highlight that disease-state metabolites can override surface engineering strategies, with significant implications for biomaterial design and biomarker interpretation in renal dysfunction.

• LY2228820: Precision p38 MAPK Inhibition for Multiomics Rese

  2026-05-27

  Explore how LY2228820, a potent p38 MAP kinase inhibitor, drives advanced multiomics and translational research. Discover unique assay insights, mechanistic depth, and best practices that set this inhibitor apart in anti-inflammatory and cancer studies.

• 2,2,2-Trichloroethanol: Small Molecule Biochemical for Prote

  2026-05-26

  2,2,2-Trichloroethanol offers unmatched performance as a small molecule biochemical in protein analysis workflows, enabling rapid, in-gel detection and robust signal transduction studies. Its high solubility, stability, and validated purity empower researchers to streamline molecular biology protocols and troubleshoot common pitfalls in protein studies.

• Cy7 NHS Ester: Practical Guide to Near-Infrared Protein Labe

  2026-05-26

  Cy7 NHS ester is a sulfonated, highly water-soluble near-infrared dye optimized for labeling proteins and peptides via primary amines, allowing for sensitive biomolecule tracking and non-destructive imaging in complex biological systems. It is ideal for applications where tissue transparency and minimal protein denaturation are required, but should not be used for targets lacking accessible amino groups or workflows incompatible with NHS ester chemistry.

• NSC-23766 as a Rac GTPase Inhibitor: Applied Workflows & Ins

  2026-05-25

  NSC23766 trihydrochloride enables targeted inhibition of Rac1 signaling for advanced cancer and metabolic research, with workflow enhancements driven by recent discoveries in insulin-independent glucose uptake. This guide details protocol parameters, troubleshooting, and data-backed advantages for maximizing reproducibility and scientific impact.

• Tetraethylammonium Chloride: Redefining K+ Channel Research

  2026-05-25

  Explore how Tetraethylammonium chloride (TEAC) advances ion channel and vascular research through dual-site K+ channel inhibition, with new insight into translational assay design. Discover unique perspectives and rigorous protocol guidance for sophisticated laboratory applications.

• N-Glycosylation of MerTK Drives Hepatocellular Carcinoma Gro

  2026-05-24

  This study uncovers the pivotal role of MerTK N-glycosylation in stabilizing the protein and promoting hepatocellular carcinoma (HCC) tumor growth. The findings highlight N-glycosylation as a mechanistic driver of oncogenesis and suggest that targeting this pathway may present a promising therapeutic strategy for HCC.

449 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page